UBS Group
CRXTW

UBS Group’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

UBS Group’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-22,242
Closed -$2K – 10434
2022
Q2 		$2K Buy
+22,242
New +$2K ﹤0.01% 8718